Post-translational Modifications: Reversing ADP-ribosylation
Interactions between serines and molecules of ADP-ribose play an important role in signaling that the DNA in a cell has been damaged and needs to be repaired.
- Ludwig-Maximilians-University of Munich, Germany
- Biological Research Center of the Hungarian Academy of Sciences, Hungary
Cells rapidly react to stimuli in their environment by making modifications to proteins that change the way those proteins interact with other molecules (Mann and Jensen, 2003). Once a stimulus has stopped, these 'post-translational modifications' are usually reversed and the cell’s life goes back to normal. For example, when a cell suffers damage to its DNA, the addition of a molecule called ADP-ribose – a process that is known as ADP-ribosylation – to certain proteins sends a signal that leads to the damage being repaired; drugs that inhibit the addition of ADP-ribose are also used in cancer therapy (see Li and Yu, 2015 for a review).
It was discovered in the 1960s that specialized enzymes called PARPs can add one or more units of ADP-ribose (ADPr) to specific amino acids within proteins. Over the decades, it became clear that these enzymes are involved in a wide range of cellular processes, including DNA repair, transcription, chromatin regulation and cell death. The first target sites for ADP-ribosylation to be identified were mostly glutamates, aspartates and lysines, and the enzymes responsible for the removal of the ADPr units were also established (Figure 1)(Barkauskaite et al., 2013).
Figure 1
Mono- and poly(ADP-ribosyl)ation and their reversal.
When a protein (top) undergoes mono(ADP-ribosyl)ation the ADP-ribose (red circle) can be added to a glutamate (Glu) or aspartate (Asp; left) or a serine (Ser; right). It is also possible for multiple units of ADP-ribose to be added to a protein at a given target site in a process known as poly(ADP-ribosyl)ation (bottom). The enzymes PARP1 and PARP2 are involved in ADP-ribosylation of both Glu/Asp and Ser, with a protein called HPF1 acting as a cofactor in the mono(ADP-ribosyl)ation of Ser. The enzymes involved in the reversal of both mono- and poly(ADP-ribosyl)ation are shown. Fontana et al. have shown that ARH3 is exclusively responsible for reversing the mono(ADP-ribosyl)ation of Ser, and that it is also involved (with PARG) in reversing the poly(ADP-ribosyl)ation of Ser.
More recently, it was shown that serines can be target sites for ADP-ribosylation, and that many of the proteins that contain such target sites have important roles in DNA damage repair (Bilan et al., 2017; Bonfiglio et al., 2017; Leidecker et al., 2016; Gibbs-Seymour et al., 2016). However, nothing was known about the enzymes or mechanisms responsible for the removal of the ADPr units from the serines. Now, in eLife, Ivan Ahel of the University of Oxford, Ivan Matic of the Max Planck Institute for Biology of Ageing in Cologne and co-workers – including Pietro Fontana, Juan José Bonfiglio and Luca Palazzo as joint first authors, along with Edward Bartlett – provide new insight into these matters (Fontana et al., 2017).
Using biochemical approaches and a technique called mass spectrometry, Fontana et al. screened a number of proteins that are known to bind to ADPr to find out if they could remove ADPr units that had been added to serines. They discovered that an enzyme called ARH3 could remove ADPr from serine on histone proteins (Figure 1). Previous research has shown that ARH3 and PARG work in similar ways. Both enzymes are able to break the ribose bonds that hold chains of ADPr units together, but ARH3 hydrolyses the chains less efficiently than PARG and also has a different structure (Mueller-Dieckmann et al., 2006; Oka et al., 2006). Fontana et al. discovered that unlike PARG, ARH3 was able to cleave both single ADPr units and chains of ADPr on histones and other proteins.
Since mass spectrometry is a rather expensive and laborious technique, Fontana et al. also used ARH3 in combination with western blotting – a basic technique to detect specific proteins or protein modifications – to track ADP-ribosylation on serines. These experiments confirmed the findings obtained with mass spectrometry, and proved that histone proteins are primarily – if not exclusively – modified on serine. Future studies could build on these findings and use ARH3 as a tool to detect the ADP-ribosylation of serines in proteins.
Despite these new insights, many outstanding questions remain. For example, how does adding ADPr to serine affect the role of a protein? And what happens when two neighboring amino acids experience post-translational modifications? A widely studied post-translational modification that regulates gene expression involves the methylation or acetylation of two lysines (K9 and K27) in histone three (Saksouk et al., 2015). However, these lysines are followed by a serine, which could undergo its own post-translation modification (which could be phosphorylation or ADP-ribosylation). Would these modifications influence each other? Probably, yes. This complex interplay may have far reaching consequences in the regulation of gene expression, and may play an important role in many diseases that depend on ADP-ribosylation pathways.
References
-
The recognition and removal of cellular poly(ADP-ribose) signalsFEBS Journal 280:3491–3507.https://doi.org/10.1111/febs.12358
-
Serine ADP-ribosylation depends on HPF1Molecular Cell 65:932–940.https://doi.org/10.1016/j.molcel.2017.01.003
-
Serine is a new target residue for endogenous ADP-ribosylation on histonesNature Chemical Biology 12:998–1000.https://doi.org/10.1038/nchembio.2180
-
Proteomic analysis of post-translational modificationsNature Biotechnology 21:255–261.https://doi.org/10.1038/nbt0303-255
-
Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolaseJournal of Biological Chemistry 281:705–713.https://doi.org/10.1074/jbc.M510290200
-
Constitutive heterochromatin formation and transcription in mammalsEpigenetics & Chromatin 8:3.https://doi.org/10.1186/1756-8935-8-3
Article and author information
Author details
Giuliana Katharina Moeller
Publication history
- Version of Record published: August 10, 2017 (version 1)
Copyright
© 2017, Moeller et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,092
- Page views
-
- 135
- Downloads
-
- 1
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Post-translational Modifications: Reversing ADP-ribosylation
eLife 6:e29942.
https://doi.org/10.7554/eLife.29942
Further reading
-
- Biochemistry and Chemical Biology
- Cancer Biology
Identification oncogenes is fundamental to revealing the molecular basis of cancer. Here, we found that FOXP2 is overexpressed in human prostate cancer cells and prostate tumors, but its expression is absent in normal prostate epithelial cells and low in benign prostatic hyperplasia. FOXP2 is a FOX transcription factor family member and tightly associated with vocal development. To date, little is known regarding the link of FOXP2 to prostate cancer. We observed that high FOXP2 expression and frequent amplification are significantly associated with high Gleason score. Ectopic expression of FOXP2 induces malignant transformation of mouse NIH3T3 fibroblasts and human prostate epithelial cell RWPE-1. Conversely, FOXP2 knockdown suppresses the proliferation of prostate cancer cells. Transgenic overexpression of FOXP2 in the mouse prostate causes prostatic intraepithelial neoplasia. Overexpression of FOXP2 aberrantly activates oncogenic MET signaling and inhibition of MET signaling effectively reverts the FOXP2-induced oncogenic phenotype. CUT&Tag assay identified FOXP2-binding sites located in MET and its associated gene HGF. Additionally, the novel recurrent FOXP2-CPED1 fusion identified in prostate tumors results in high expression of truncated FOXP2, which exhibit a similar capacity for malignant transformation. Together, our data indicate that FOXP2 is involved in tumorigenicity of prostate.
-
- Biochemistry and Chemical Biology
- Cell Biology
Pancreatic a-cells secrete glucagon, an insulin counter-regulatory peptide hormone critical for the maintenance of glucose homeostasis. Investigation of the function of human a-cells remains a challenge due to the lack of cost-effective purification methods to isolate high-quality a-cells from islets. Here, we use the reaction-based probe diacetylated Zinpyr1 (DA-ZP1) to introduce a novel and simple method for enriching live a-cells from dissociated human islet cells with ~ 95% purity. The a-cells, confirmed by sorting and immunostaining for glucagon, were cultured up to 10 days to form a-pseudoislets. The a-pseudoislets could be maintained in culture without significant loss of viability, and responded to glucose challenge by secreting appropriate levels of glucagon. RNA-sequencing analyses (RNA-seq) revealed that expression levels of key a-cell identity genes were sustained in culture while some of the genes such as DLK1, GSN, SMIM24 were altered in a-pseudoislets in a time-dependent manner. In conclusion, we report a method to sort human primary a-cells with high purity that can be used for downstream analyses such as functional and transcriptional studies.
